All News


 

2021

October

Media Release / Oct 04, 2021

Sandoz Canada launches PrSandoz® Dimethyl Fumarate Delayed-Release Capsules, a generic equivalent to PrTecfidera

Read More

September

Media Release / Sep 01, 2021

Sandoz Canada launches PrSandoz® Lenalidomide, a generic equivalent to PrRevlimid®

Read More

June

Media Release / Jun 02, 2021

Biosimilars reimbursement update: Ontario adds Inclunox™ to its list of reimbursed drugs

Read More

May

Media Release / May 28, 2021

Accessa and Québec owner-pharmacists make their debut in the Patient Support Program sector with Sandoz Canada's Hyrimoz

Read More
Media Release / May 18, 2021

Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars

Read More
Media Release / May 17, 2021

Sandoz Canada launches its 6th biosimilar with PrInclunox® and PrInclunox® HP

Read More
Media Release / May 12, 2021

A first in Canada: generic version of pirfenidone

Read More

April

Media Release / Apr 27, 2021

Novartis Q1 2021 Financial Results

Read More
Media Release / Apr 21, 2021

New biosimilar switch policy in New Brunswick improves patient access to safe and effective medicines

Read More
Media Release / Apr 13, 2021

Third consecutive recognition for Novartis in Canada as a Great Place to Work®

Read More